HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-SEP-14 4RCP TITLE CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 372-599; COMPND 5 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE COMPND 6 13, STPK13; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PL-2; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: UNP RESIDUES 1-5; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK, PLK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES KEYWDS POLO-BOX DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.LEE,J.H.SONG,H.Y.KIM REVDAT 3 21-JAN-15 4RCP 1 JRNL REVDAT 2 19-NOV-14 4RCP 1 REMARK REVDAT 1 12-NOV-14 4RCP 0 JRNL AUTH M.AHN,Y.H.HAN,J.E.PARK,S.KIM,W.C.LEE,S.J.LEE,P.GUNASEKARAN, JRNL AUTH 2 C.CHEONG,S.Y.SHIN,H.Y.KIM,E.K.RYU,R.N.MURUGAN,N.H.KIM, JRNL AUTH 3 J.K.BANG JRNL TITL A NEW CLASS OF PEPTIDOMIMETICS TARGETING THE POLO-BOX DOMAIN JRNL TITL 2 OF POLO-LIKE KINASE 1. JRNL REF J.MED.CHEM. V. 58 294 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25347203 JRNL DOI 10.1021/JM501147G REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 29555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1464 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1995 REMARK 3 BIN R VALUE (WORKING SET) : 0.2316 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1854 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 163 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.24900 REMARK 3 B22 (A**2) : 4.87100 REMARK 3 B33 (A**2) : -3.62200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.69500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.104 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.707 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.128 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.131 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 50.64 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : EDO.PAR REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : CNS_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : CNS_TOPPAR:CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 6 : CAPPING.PAR REMARK 3 PARAMETER FILE 7 : 56A.PAR REMARK 3 PARAMETER FILE 8 : TPO.PAR REMARK 3 PARAMETER FILE 9 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : EDO.TOP REMARK 3 TOPOLOGY FILE 3 : CNS_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : CNS_TOPPAR:ION.TOP REMARK 3 TOPOLOGY FILE 5 : CNS_TOPPAR:CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 6 : CAPPING.TOP REMARK 3 TOPOLOGY FILE 7 : 56A.TOP REMARK 3 TOPOLOGY FILE 8 : TPO.TOP REMARK 3 TOPOLOGY FILE 9 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RCP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-SEP-14. REMARK 100 THE RCSB ID CODE IS RCSB087182. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9800 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30636 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.36500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CITRATE PH 4.0, 500MM REMARK 280 AMMONIUM SULFATE, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.63500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE PL-2 IS POLYPEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: PL-2 REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 503 REMARK 465 GLU A 504 REMARK 465 LEU A 505 REMARK 465 ALA A 506 REMARK 465 ARG A 507 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 420 -37.86 -137.90 REMARK 500 ASN A 446 0.38 -69.47 REMARK 500 ASP A 449 -38.33 -138.81 REMARK 500 LEU A 490 152.55 72.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 609 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 610 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF PL-2 DBREF 4RCP A 372 599 UNP P53350 PLK1_HUMAN 372 599 DBREF 4RCP B 1 5 PDB 4RCP 4RCP 1 5 SEQRES 1 A 228 CYS HIS LEU SER ASP MET LEU GLN GLN LEU HIS SER VAL SEQRES 2 A 228 ASN ALA SER LYS PRO SER GLU ARG GLY LEU VAL ARG GLN SEQRES 3 A 228 GLU GLU ALA GLU ASP PRO ALA CYS ILE PRO ILE PHE TRP SEQRES 4 A 228 VAL SER LYS TRP VAL ASP TYR SER ASP LYS TYR GLY LEU SEQRES 5 A 228 GLY TYR GLN LEU CYS ASP ASN SER VAL GLY VAL LEU PHE SEQRES 6 A 228 ASN ASP SER THR ARG LEU ILE LEU TYR ASN ASP GLY ASP SEQRES 7 A 228 SER LEU GLN TYR ILE GLU ARG ASP GLY THR GLU SER TYR SEQRES 8 A 228 LEU THR VAL SER SER HIS PRO ASN SER LEU MET LYS LYS SEQRES 9 A 228 ILE THR LEU LEU LYS TYR PHE ARG ASN TYR MET SER GLU SEQRES 10 A 228 HIS LEU LEU LYS ALA GLY ALA ASN ILE THR PRO ARG GLU SEQRES 11 A 228 GLY ASP GLU LEU ALA ARG LEU PRO TYR LEU ARG THR TRP SEQRES 12 A 228 PHE ARG THR ARG SER ALA ILE ILE LEU HIS LEU SER ASN SEQRES 13 A 228 GLY SER VAL GLN ILE ASN PHE PHE GLN ASP HIS THR LYS SEQRES 14 A 228 LEU ILE LEU CYS PRO LEU MET ALA ALA VAL THR TYR ILE SEQRES 15 A 228 ASP GLU LYS ARG ASP PHE ARG THR TYR ARG LEU SER LEU SEQRES 16 A 228 LEU GLU GLU TYR GLY CYS CYS LYS GLU LEU ALA SER ARG SEQRES 17 A 228 LEU ARG TYR ALA ARG THR MET VAL ASP LYS LEU LEU SER SEQRES 18 A 228 SER ARG SER ALA SER ASN ARG SEQRES 1 B 5 ACE 56A SER TPO NH2 MODRES 4RCP 56A B 2 HIS 3-(8-PHENYLOCTYL)-L-HISTIDINE MODRES 4RCP TPO B 4 THR PHOSPHOTHREONINE HET ACE B 1 3 HET 56A B 2 24 HET TPO B 4 11 HET NH2 B 5 1 HET EDO A 601 4 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET EDO A 605 4 HET EDO A 606 4 HET EDO A 607 4 HET EDO A 608 4 HET EDO A 609 4 HET EDO A 610 4 HETNAM ACE ACETYL GROUP HETNAM 56A 3-(8-PHENYLOCTYL)-L-HISTIDINE HETNAM TPO PHOSPHOTHREONINE HETNAM NH2 AMINO GROUP HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 ACE C2 H4 O FORMUL 2 56A C20 H29 N3 O2 FORMUL 2 TPO C4 H10 N O6 P FORMUL 2 NH2 H2 N FORMUL 3 EDO 10(C2 H6 O2) FORMUL 13 HOH *163(H2 O) HELIX 1 1 HIS A 373 SER A 387 1 15 HELIX 2 2 ARG A 396 GLU A 401 5 6 HELIX 3 3 ASP A 402 ILE A 406 5 5 HELIX 4 4 PRO A 469 SER A 471 5 3 HELIX 5 5 LEU A 472 HIS A 489 1 18 HELIX 6 6 LEU A 564 GLY A 571 1 8 HELIX 7 7 CYS A 573 ASN A 598 1 26 SHEET 1 A 6 VAL A 411 ASP A 416 0 SHEET 2 A 6 GLY A 422 LEU A 427 -1 O GLY A 424 N VAL A 415 SHEET 3 A 6 VAL A 432 PHE A 436 -1 O GLY A 433 N TYR A 425 SHEET 4 A 6 ARG A 441 LEU A 444 -1 O LEU A 444 N VAL A 432 SHEET 5 A 6 SER A 450 ILE A 454 -1 O ILE A 454 N ARG A 441 SHEET 6 A 6 GLU A 460 THR A 464 -1 O LEU A 463 N LEU A 451 SHEET 1 B 6 LEU A 511 ARG A 516 0 SHEET 2 B 6 ALA A 520 LEU A 525 -1 O ILE A 522 N PHE A 515 SHEET 3 B 6 VAL A 530 PHE A 534 -1 O GLN A 531 N LEU A 523 SHEET 4 B 6 LYS A 540 CYS A 544 -1 O LEU A 543 N VAL A 530 SHEET 5 B 6 ALA A 549 ILE A 553 -1 O ILE A 553 N LYS A 540 SHEET 6 B 6 PHE A 559 ARG A 563 -1 O TYR A 562 N VAL A 550 LINK C ACE B 1 N 56A B 2 1555 1555 1.34 LINK C 56A B 2 N SER B 3 1555 1555 1.33 LINK C SER B 3 N TPO B 4 1555 1555 1.34 LINK C TPO B 4 N NH2 B 5 1555 1555 1.33 SITE 1 AC1 6 GLN A 379 ASP A 416 TYR A 417 SER A 418 SITE 2 AC1 6 ASP A 419 HOH A 779 SITE 1 AC2 5 GLY A 393 GLU A 455 ARG A 456 ASP A 457 SITE 2 AC2 5 HOH A 728 SITE 1 AC3 5 CYS A 372 HIS A 373 ASP A 376 TYR A 421 SITE 2 AC3 5 56A B 2 SITE 1 AC4 7 GLN A 380 TYR A 481 TYR A 485 PRO A 545 SITE 2 AC4 7 LEU A 546 HOH A 767 56A B 2 SITE 1 AC5 5 GLU A 401 ILE A 406 PHE A 559 ARG A 560 SITE 2 AC5 5 THR A 561 SITE 1 AC6 8 GLY A 393 LEU A 394 VAL A 395 TYR A 453 SITE 2 AC6 8 SER A 471 LEU A 472 HOH A 820 HOH A 834 SITE 1 AC7 5 LYS A 420 TYR A 421 PHE A 436 ASN A 437 SITE 2 AC7 5 ASP A 438 SITE 1 AC8 2 TRP A 514 PHE A 515 SITE 1 AC9 5 PHE A 534 GLN A 536 ASP A 537 ARG A 579 SITE 2 AC9 5 HOH A 739 SITE 1 BC1 5 LYS A 413 GLU A 488 HIS A 489 LEU A 490 SITE 2 BC1 5 HOH A 783 SITE 1 BC2 27 ASP A 376 GLN A 379 SER A 383 LYS A 413 SITE 2 BC2 27 TRP A 414 VAL A 415 ASP A 416 TYR A 421 SITE 3 BC2 27 TYR A 481 TYR A 485 LEU A 490 LEU A 491 SITE 4 BC2 27 HIS A 538 LYS A 540 GLU A 568 EDO A 603 SITE 5 BC2 27 EDO A 604 HOH A 702 HOH A 729 HOH B 201 SITE 6 BC2 27 HOH B 202 HOH B 203 HOH B 204 HOH B 205 SITE 7 BC2 27 HOH B 206 HOH B 207 HOH B 208 CRYST1 39.390 61.270 51.260 90.00 103.27 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025387 0.000000 0.005987 0.00000 SCALE2 0.000000 0.016321 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020044 0.00000